Physiology of Mechanotransduction: How Do Muscle and Bone “Talk-to One Another?

详细信息    查看全文

• 作者：Janalee Isaacson (1) (2)
  Marco Brotto (1) (3) (4)
  
• 关键词：Bones ; Cross talk ; Bone–muscle cross talk ; Mechanostat ; Muscles ; Musculoskeletal ; Myokines ; Osteoporosis ; Sarcopenia
• 刊名：Clinical Reviews in Bone and Mineral Metabolism
• 出版年：2014
• 出版时间：June 2014
• 年：2014
• 卷：12
• 期：2
• 页码：77-85
• 全文大小：
• 参考文献：1. Ioannidis I. The road from obesity to type 2 diabetes. Angiology. 2008;59(Supp 2):39S-3S. CrossRef
  2. Berg AH, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7(8):947-3. CrossRef
  3. Sell H, Dietze-Schroeder D, Eckel J. The adipocyte–myocyte axis in insulin resistance. Trends Endocrinol Metab. 2006;17(10):416-2. CrossRef
  4. Lafontan M. Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways. AJP Cell Physiol. 2011;302:C327-9. CrossRef
  5. Begg DP, Woods SC. The endocrinology of food intake. Nat Rev Endocrinol. 2013;9:584-7. CrossRef
  6. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years live with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163-6. CrossRef
  7. Frost HM. Perspectives: a proposed general model of the “mechanostat-(suggestions from a new skeletal-biologic paradigm). Anat Rec. 1996;244:139-7. CrossRef
  8. Marotti G, Ferretti M, Muglia MA, Palumbo C, Palazzini S. A quantitative evaluation of osteoblast–osteocyte relationships on growing endosteal surface of rabbit tibiae. Bone. 1992;13:363-. CrossRef
  9. Tanaka K, Matsuo T, Ohta M, Sato T, Tezuka K, Nijweide PJ, et al. Time-lapse microcinematography of osteocytes. Miner Electrolyte Metab. 1995;21:189-2.
  10. Klein-Nulend J, van der Plas A, Semeins CM, Ajubi NE, Frangos JA, Nijweide PJ, et al. Sensitivity of osteocytes to biomechanical stress in vitro. FASB J. 1995;9:441-.
  11. Burger EH, Klein-Nulend J. Mechanotransduction in bone—role of the lacuna-canalicular network. FASEB J. 1999;13:101-2.
  12. Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, et al. Osteocyte control of one formatin via sclerostin, a novel BMP antagonist. EMBO J. 2003;22:6267-6. CrossRef
  13. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of Fgf23 demonstrates an essential physiologyical role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113:561-. CrossRef
  14. Bonewald LF, Wacker MJ. FGF23 production by osteocytes. Pediatr Nephrol. 2012;28:563-. CrossRef
  15. Martin A, Liu S, David V, Li H, Karydis A, Feng JQ, et al. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J. 2011;25:2551-2. CrossRef
  16. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002;2:389-06. CrossRef
  17. Lajeunesse D, Kiebzak GM, Frondoza C, Sacktor B. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Miner. 1991;14:237-0. CrossRef
  18. Ducy P, Desbois C, Boyce B, Pinero G, et al. Increased bone formation in osteocalcin-deficient mice. Nature. 1996;382:448-2. CrossRef
  19. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747-4. CrossRef
  20. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-9. CrossRef
  21. Agas D, Marchetti L, Hurley MM, Sabbieti MG. Prostablandin F2α: a bone remodeling mediator. J Cell Physiol. 2013;228:25-. CrossRef
  22. Mo C, Romero-Suarez S, Brotto MA. Pge2 accelerates myogenesis of C2C12 myoblasts. Biophys J. 2011;100:288a. CrossRef
  23. Karsenty G, Ferron M. The contribution of bone to whole-organism physiology. Nature. 2012;481:314-0. CrossRef
  24. Orestes-Cardoso SM, Nefussi JR, Hotton D, Mesbah M, Orestes-Cardoso MDS, Robert B, et al. Postnatal Msx1 expression pattern in craniofacial, axial, and appendicular skeleton of transgenic mice from the first week until the second year. Dev Dyn. 2001;221:1-3. CrossRef
  25. Pearson OM, Lieberman DE. The aging of Wolff’s law: ontogeny and responses to mechanical loading in cortical bone. Am J Phys Anthropol. 2004;125:63-9. CrossRef
  26. Lang TF. The bone–muscle relationship in men and women. J Osteoporos. 2011;2011:1-. CrossRef
  27. Zanchetta JR, Plotkin H, Filgueira MLA. Bone mass in children: normative values for the 2-0-year-old population. Bone. 1995;16:S393-.
  28. Wang Q, Alen M, Nicholson P, Suominen H, Koistinen A, Kroger H, et al. Weight-bearing, muscle loading and bone mineral accrual in pubertal girls—a 2-year longitudinal study. Bone. 2007;40:1196-02. CrossRef
  29. Hirokawa N, Niwa S, Tanaka Y. Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron. 2010;68:610-8. CrossRef
  30. Gomez-Pinilla F. Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. J Neurophysiol. 2002;88:2187-5. CrossRef
  31. Goldspink DF, Goldspink G. The role of passive stretch in retarding muscle atrophy. In: Nix WA, Vrbova G, editors. Electrical stimulation and neuromuscular disorders. Berlin: Springer; 1986. p. 91-00. CrossRef
  32. Kurek JB, Bower JJ, Romanella M, Koentgen F, Murphy M, Austin L. The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve. 1997;20:815-2. CrossRef
  33. Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, et al. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil. 2003;24:113-. CrossRef
  34. Steensberg A, Hall G, Osada T, Sacchetti M, Saltin B, Pedersen BK. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol. 2000;529:237-2. CrossRef
  35. Andersen K, Pedersen B. The role of inflammation in vascular insulin resistance with focus on IL-6. Horm Metab Res. 2008;40:635-. CrossRef
  36. Keller C. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J. 2001;15(14):2748-0.
  37. Nielsen AR, Pedersen BK. The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab. 2007;32:833-. CrossRef
  38. Pedersen BK, Akerstrom TCA, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. J Appl Physiol. 2007;103:1093-. CrossRef
  39. Matthews VB, Astrom MB, Chan MHS, Bruce CR, Krabbe KS, Prelovsek O, et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia. 2009;52:1409-8. CrossRef
  40. Pedersen L, Olsen CH, Pedersen BK, Hojman P. Muscle-derived expression of the chemokine CXCL1 attenuates diet-induced obesity and improves fatty acid oxidation in the muscle. AJP Endocrinol Metab. 2012;302:E831-0. CrossRef
  41. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol. 2002;161:895-07. CrossRef
  42. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature. 2008;454:961-. CrossRef
  43. Hee Park K, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98(12):4899-07.
  44. Chan JKK, Harry L, Williams G, Nanchahal J. Soft-tissue reconstruction of open fractures of the lower limb: muscle versus fasciocutaneous flaps. Plast Reconstr Surg. 2012;130:284e-5e. CrossRef
  45. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member. Nature. 1997;387:83-0. CrossRef
  46. Jouliaekaza D, Cabello G. The myostatin gene: physiology and pharmacological relevance. Curr Opin Pharmacol. 2007;7:310-. CrossRef
  47. Zimmers TA. Induction of cachexia in mice by systemically administered myostatin. Science. 2002;296:1486-. CrossRef
  48. Hamrick MW, McPherron AC, Lovejoy CO. Bone mineral content and density in humerus of adult myostatin-deficient mice. Calcif Tissue Int. 2002;71:63-. CrossRef
  49. Hamrick MW. Increased bone mineral density in the femora of GDF8 knockout mice. Anat Rec. 2003;272A:388-1. CrossRef
  50. Hamrick MW, Samaddar T, Pennington C, McCormick J. Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise. J Bone Miner Res. 2005;21:477-3. CrossRef
  51. Morissette MR, Stricker JC, Rosenberg MA, Buranasombati C, Levitan EB, Mittleman MA, et al. Effects of myostatin deletion in aging mice. Aging Cell. 2009;8:573-3. CrossRef
  52. Coiro V, Volpi R, Cataldo S, Magotti MG, Maffei ML, Giumelli C, et al. Effect of physiological exercise on osteocalcin levels in subjects with adrenal incidentaloma. J Endocrinol Invest. 2012;35:357-. CrossRef
  53. Centers for Disease Control and Prevention (US); Prevalence of obesity among older adults in the United States, 2007-010. 2012. (NCHS Data Brief; no. 106).
  54. Beltran-Sanchez H, Harhay MO, Harhay MM, McElliogott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-010. J Am Coll Cardiol. 2013;62(8):697-03. CrossRef
  55. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137:231-3. CrossRef
  56. Karakelides H, Nair KS. Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol. 2005;68:123-8. CrossRef
  57. Cosqueric G, Sebag A, Ducolombier C, Thomas C, Piette F, Weill-Engerer S. Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr. 2006;96(5):895-01. CrossRef
  58. Kalantar-Zadeh K, Rhee C, Sim JJ, Stenvinkel P, Anker SD, Kovesdy CP. Why cachexia kills: examining the causality of poor outcomes in wasting conditions. J Cachexia Sarcopenia Muscle. 2013;4:89-4. CrossRef
  59. Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437-8. CrossRef
  60. Jensen GL, Friedmann JM. Obesity is associated with functional decline in community-dwelling rural older persons. J Am Geriatr Soc. 2002;50(5):918-3. CrossRef
  61. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One. 2010;5(5):1-. CrossRef
  62. Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes. Diabetes Care. 2010;33(7):1497-. CrossRef
  63. Magkos F, Wang X, Mittendorfer B. Metabolic actions of insulin in men and women. Nutrition. 2010;26(7-):686-3. CrossRef
  64. Lee CG, Boyko EJ, Strotmeyer ES, Lewis CE, Cawthon PM, Hoffman AR, et al. Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus. J Am Geriatr Soc. 2011;59:1217-4. CrossRef
  65. Hofbauer LG, Brueck C, Singh SK, Dobnig H. Osteoporosis in patients with diabetes mellitus. JBMR. 2007;22(9):1317-8. CrossRef
  66. Strotmeyer ES, Cauley JA. Diabetes mellitus, bone mineral density, and fracture risk. Curr Opin Endocrinol Diabetes Obes. 2007;14:429-5. CrossRef
  67. Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int. 2009;84:45-5. CrossRef
  68. Hamann C, Kirschner S, Gunther KP, Hofbauer LC. Bone sweet bone—osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol. 2012;8:297-05. CrossRef
  
• 作者单位：Janalee Isaacson (1) (2)
  Marco Brotto (1) (3) (4)
  
  1. Muscle Biology Research Group-MUBIG, School of Nursing and Health Studies, University of Missouri-Kansas City (UMKC), 2464 Charlotte St, Kansas City, MO, 64108, USA
  2. Nursing Program, Johnson County Community College, Overland Park, KS, 66210, USA
  3. School of Medicine, UMKC, Kansas City, MO, USA
  4. School of Pharmacy, UMKC, Kansas City, MO, USA
  
• ISSN：1559-0119

文摘

The complexity of cell interactions with their microenvironment and their ability to communicate at the autocrine, paracrine, and endocrine levels has gradually but significantly evolved in the last three decades. The musculoskeletal system has been historically recognized to be governed by a relationship of proximity and function, chiefly dictated by mechanical forces and the work of gravity itself. In this review article, we first provide a historical overview of the biomechanical theory of bone–muscle interactions. Next, we expand to detail the significant evolution in our understanding of the function of bones and muscles as secretory organs. Then, we review and discuss new evidence in support of a biochemical interaction between these two tissues. We then propose that these two models of interaction are complementary and intertwined providing for a new frontier for the investigation of how bone–muscle cross talk could be fully explored for the targeting of new therapies for musculoskeletal diseases, particularly the twin conditions of aging, osteoporosis and sarcopenia. In the last section, we explore the bone–muscle cross talk in the context of their interactions with other tissues and the global impact of these multi-tissue interactions on chronic diseases.